Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
Tweet | ||
321 | Tue, 8/6/2013, 8:30 AM - 10:20 AM | CC-516c | |
Methods and Applications in Biomedical Data and Clinical Trials, Part 1 — Contributed Papers | |||
Biopharmaceutical Section , Biometrics Section , Scientific and Public Affairs Advisory Committee | |||
Chair(s): Lisa LaVange, Food and Drug Administration, CDER | |||
8:35 AM | Pitfalls in Assessing Relative Efficacy Across Trials — Xiao Sun, Merck & Co., Inc. | ||
8:40 AM | Methods to Compare the Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Across Nine Linguistic Translations — Amylou Dueck, Mayo Clinic ; Jeff Sloan, Mayo Clinic ; Ruben Mesa, Mayo Clinic | ||
8:45 AM | Analysis of Binary Data Arising from a Prospective Cluster Randomized Study on the Diagnosis of Chronic Obstructive Pulmonary Disease Using Overdispersed Binomial Models — Santosh Sutradhar, Novartis ; Valentina Bayer Zubek, Boehringer Ingelheim Pharmaceuticals, Inc. | ||
8:50 AM | Strategy in Dichotomizing a Continuous Biomarker for Survival Data Analysis — Dung-Tsa Chen, Moffitt Cancer Center ; Ying-Lin Hsu, National Chung Hsing University, Taiwan ; Po-Yu Huang, National Chung Hsing University, Taiwan | ||
8:55 AM | M&N, Wald, and Skellam: Who Excels in Rare-Event, Small-Sample, Interval Estimation of Risk Differences? — Oliver Bautista, Merck Sharp & Dohme Corp ; Josh Chen, Merck ; Ivan S. F. Chan, Merck Research Laboratories | ||
9:00 AM | Two-Sample Test for Differences in Survival at a Fixed Time Point with Small Sample Sizes — Michael Fay, National Institute of Allergy and Infectious Diseases ; Michael Proschan, NIH ; Erica H. Brittain, National Institute of Allergy and Infectious Diseases | ||
9:05 AM | Extension of Interval Design to Finding Maximum Tolerated Combinations of Two Anti-Cancer Agents — Lixin Han, Pfizer ; Stephanie Green, Pfizer | ||
9:10 AM | Single-Arm Phase IIa Oncology Clinical Trials with Sample Size Adaptation — Bob Zhong, Johnson & Johnson | ||
9:15 AM | Detailed Description of Derivation and Display of Delinquent and Delayed Data — William Coar, Axio Research ; David Kerr, Axio Research | ||
9:20 AM | Analysis of Semi-Continuous Longitudinal Physical Activity Data — Peter John De Chavez, Northwestern University ; Lei Liu, Northwestern University ; Bonnie Spring, Northwestern University Feinberg School of Medicine ; Juned Siddique, Northwestern University | ||
9:30 AM | Skew-Elliptical Mixed-Effects Models with Time-Dependent Viral Decay Rates — Yangxin Huang, University of South Florida ; Ren Chen, University of South Florida | ||
9:35 AM | Bayesian Nonlinear Regression for Neutralization Assays Using 4- and 5-Parameter Growth Curves — James Slaughter, Vanderbilt University ; John T. Bates, Vanderbilt University ; James E. Crowe, Vanderbilt University | ||
9:45 AM | Prior-Robust Designs for Nonlinear Models — Sydney Akapame ; John J. Borkowski, Montana State University - Bozeman | ||
9:50 AM | Early Detection of Cardiovascular Signals: A Simulation Study About Power Enhancement — Jing Huang ; Ouhong Wang, Amgen ; Mike Hale, Amgen | ||
9:55 AM | Comparison of Permutation Tests and GEE Methods for Group-Randomized Trials with Count Data — Ping Xu, Axio Research Coporation ; Brian Leroux, University of Washington | ||
10:00 AM | Comparing Candidate General Surrogates of Protection — Erin Gabriel, Fred Hutchinson Cancer Research Center ; M. Elizabeth Halloran, Fred Hutchinson Cancer Research Center | ||
10:05 AM | Logistic Regression for Dichotomized Counts — John Preisser, The University of North Carolina ; Kalyan Das, University of Calcutta ; John Stamm, The University of North Carolina | ||
10:10 AM | Analysis of Left-Censored Multiplex Immunoassay Data: A Unified Approach — Elizabeth Hill, Medical University of South Carolina ; Elizabeth Slate, Florida State University | ||
10:15 AM | Floor Discussion |
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.